Global Nickel Monoxide Market Research Report

1
Oncology Drug Market Report
2
Summary
Herceptin (trastuzumab) 2006-2015 analysis
2016-2021 expectations is a comprehensive report
on the second-largest oncology drug by 2015
sales. The report provides basic information
about the drug, covering all details such as
brand name, date of approvals, mechanism of
action, molecular structure, route of
administration, etc. It has an interesting
infographic description of the approval timeline
and contains an event tracker, which covers all
the major events around the drug, news about
Herceptin, infor-mation on biosimilar filings,
number of clinical trials (by year and by phase),
clinical study data about Herceptin and other
competing drugs and so on.
www.BharatBook.com
3
The report Oncology Drug Market Report gives an
analysis of the historical annual sales (from
2006-2015), historical quarter-ly sales (Q1-2013
to Q3-2016), cumulative sales till date, Q3-2016
update and sales expecta-tions (from 2016-2021).
The analysis broadly indicates that the drug has
given a successful decade and sales will be
stable until 2016, after which they are likely to
fall. Cumulatively, Herceptin has seen sales of
USD 65 bn since its launch. Details of the sales
analysis section Historical annual sales
analysis Historical annual sales have been
analysed in USD and CHF terms with the help of
graphical representation of sales over 2006-2015.
The report has all the data in tabular format as
well. We have highlighted key reasons for the
sales trend in all the geographies
listed. Historical quarterly sales
analysis Additionally, we have sales analysis on
quarterly basis for the last 15 quarters from
Q1-2013 to Q3-2016. The quarterly data is also in
graphical as well as tabular format.
www.BharatBook.com
4
(No Transcript)
5
Expected sales analysis The report has our
expectations for sales of Herceptin over
2016-2021. We have highlighted key reasons for
our expectations. All the historical as well as
ex-pected sales analysis is based on 1. Total
global sales 2. US sales 3. International
sales a. Europe sales b. Japan sales c. RoW
sales Other important details Key event
tracker The report highlights key events that
have taken place for Herceptin from 2005 to 2015.
It gives additional information about which key
events have driven sales for Herceptin over this
period.
www.BharatBook.com
6
Competitive drugs We have provided information
on competitor drugs in the market that are used
in the treatment of the same indications as
Herceptin with their details including brand
name, API, company, class of drug, therapy class
and treatment preference. Clinical trials
numbers The report provides numbers of clinical
trials which have started for Herceptin in 2016,
2015 and 2014 and for different phases phase
III, phase III/II and phase II. It gives insights
into whether the company is still spending money
for taking the drug even further for other
indications or in combination therapies. Clinical
studies Efficacy results of Herceptin and its
competing drugs have been provided.
www.BharatBook.com
7
Biosimilar filings Herceptin is already
off-patent in Japan and Europe but not in the US.
From this perspective, we have listed the players
who have filed for (and conducting trials of)
biosimilars of Herceptin as this can be potential
competition for Roche, going forward. News We
have listed news related to Herceptin that would
impact the drugs performance Key event
tracker The report highlights key events that
have taken place for Votrient from 2005 to 2015.
It gives additional information about the key
events that have driven sales for the drug over
this period.
www.BharatBook.com
8
Table of Contents

• Basic Information
• Approval timeline infographic (1998-2014)
• Regulatory approval details (US, Europe, Japan
  and RoW)
• Historical annual sales analysis (2006-2015,
  2016E)
• Historical quarterly sales analysis (Q1-2013 to
  Q3-2016)
• Historical cumulative sales (1998 to Q3-2016)
• Q3-2016 update
• Sales expectations (2016E-2021E)
• Biosimilar filings
• List of key approved drugs in breast cancer
• List of key approved drugs in gastric cancer
• Event tracker
• Clinical trials of Herceptin (US)
• News around Herceptin

www.BharatBook.com
9
Full Reports
Oncology Drug Market Report
Bharat Book Bureau Tel [phone] /
27810773 Email poonam_at_bharatbook.com Website
www.bharatbook.com FaceBook BharatBook3B Twitter
ResearchBook LinkedIn Bharat Book Bureau